[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DK3368044T3 - Behandling af hepatisk steatose-relateret oligo-ovulation - Google Patents

Behandling af hepatisk steatose-relateret oligo-ovulation Download PDF

Info

Publication number
DK3368044T3
DK3368044T3 DK16788501.1T DK16788501T DK3368044T3 DK 3368044 T3 DK3368044 T3 DK 3368044T3 DK 16788501 T DK16788501 T DK 16788501T DK 3368044 T3 DK3368044 T3 DK 3368044T3
Authority
DK
Denmark
Prior art keywords
steatose
ovulation
hepatic
treatment
related oligo
Prior art date
Application number
DK16788501.1T
Other languages
English (en)
Inventor
Zegher Francis De
Lourdes Ibáñez
Original Assignee
Univ Leuven Kath
Sant Joan De Deu Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Leuven Kath, Sant Joan De Deu Hospital filed Critical Univ Leuven Kath
Application granted granted Critical
Publication of DK3368044T3 publication Critical patent/DK3368044T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/155Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK16788501.1T 2015-10-27 2016-10-27 Behandling af hepatisk steatose-relateret oligo-ovulation DK3368044T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1518979.8A GB201518979D0 (en) 2015-10-27 2015-10-27 Treatment of hepatic steatosis related oligo-ovulation
PCT/EP2016/075953 WO2017072243A1 (en) 2015-10-27 2016-10-27 Treatment of hepatic steatosis related oligo-ovulation

Publications (1)

Publication Number Publication Date
DK3368044T3 true DK3368044T3 (da) 2021-09-13

Family

ID=55130283

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16788501.1T DK3368044T3 (da) 2015-10-27 2016-10-27 Behandling af hepatisk steatose-relateret oligo-ovulation

Country Status (24)

Country Link
US (2) US20190060328A1 (da)
EP (2) EP3368044B1 (da)
JP (2) JP6999903B2 (da)
KR (1) KR102608158B1 (da)
CN (2) CN117379440A (da)
AR (1) AR106505A1 (da)
AU (1) AU2016344737C1 (da)
BR (1) BR112018008496A2 (da)
CA (1) CA3003076C (da)
DK (1) DK3368044T3 (da)
ES (1) ES2883282T3 (da)
GB (1) GB201518979D0 (da)
HU (1) HUE055778T2 (da)
IL (1) IL258876B (da)
LT (1) LT3368044T (da)
MA (2) MA54412A (da)
MX (2) MX2018005252A (da)
PL (1) PL3368044T3 (da)
RS (1) RS62764B1 (da)
RU (1) RU2745606C2 (da)
SI (1) SI3368044T1 (da)
TW (1) TWI791420B (da)
UY (1) UY36967A (da)
WO (1) WO2017072243A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11202005618WA (en) 2017-12-19 2020-07-29 Akouos Inc Aav-mediated delivery of therapeutic antibodies to the inner ear
CA3107945A1 (en) * 2018-08-02 2020-02-06 Hospital Sant Joan De Deu Immediate release formulation of a triple combination of active pharmaceutical ingredients useful in the treatment of polycystic ovary syndrome
EP3842803A1 (en) * 2019-12-23 2021-06-30 Katholieke Universiteit Leuven Cxcl14 in polycystic ovary syndrome
KR20230041965A (ko) 2020-05-13 2023-03-27 아카우오스, 인크. Slc26a4-연관 청력손실을 치료하기 위한 조성물 및 방법
MX2023006451A (es) 2020-12-01 2023-06-15 Akouos Inc Construcciones de anticuerpos anti-vegf y metodos relacionados para el tratamiento de los sintomas asociados al schwannoma vestibular.
AU2021412962A1 (en) 2020-12-29 2023-08-17 Akouos, Inc. Compositions and methods for treating clrn1-associated hearing loss and/or vision loss
CN118679182A (zh) 2022-02-02 2024-09-20 阿库斯股份有限公司 用于治疗前庭神经鞘瘤相关症状的抗vegf抗体构建体和相关方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5457109A (en) * 1993-09-15 1995-10-10 Warner-Lambert Company Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus
US6046222A (en) * 1993-09-15 2000-04-04 Warner-Lambert Company Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome, gestational diabetes and disease states at risk for progressing to noninsulin-dependent diabetes mellitus
WO2001062237A2 (en) * 2000-02-23 2001-08-30 Orentreich Foundation For The Advancement Of Science, Inc. Compositions for the treatment of alopecia and other disorders of the pilosebaceous apparatus
GB0106565D0 (en) * 2001-03-16 2001-05-09 Leuven K U Res & Dev Growth hormone treatment
GB0108863D0 (en) * 2001-04-10 2001-05-30 Leuven K U Res & Dev Combinational therapy
US7105489B2 (en) * 2002-01-22 2006-09-12 Amylin Pharmaceuticals, Inc. Methods and compositions for treating polycystic ovary syndrome
EP1581247A4 (en) * 2002-12-11 2007-09-12 Amylin Pharmaceuticals Inc METHODS AND COMPOSITIONS FOR TREATING STEIN-LEVENTHAL SYNDROME
GB0702537D0 (en) * 2007-02-12 2007-03-21 Leuven K U Res & Dev Treatment for excessive adiposity
US10474539B1 (en) * 2015-12-18 2019-11-12 EMC IP Holding Company LLC Browsing federated backups
CA3107945A1 (en) * 2018-08-02 2020-02-06 Hospital Sant Joan De Deu Immediate release formulation of a triple combination of active pharmaceutical ingredients useful in the treatment of polycystic ovary syndrome

Also Published As

Publication number Publication date
WO2017072243A1 (en) 2017-05-04
RU2018119146A3 (da) 2020-02-25
JP2019501113A (ja) 2019-01-17
MA54412A (fr) 2021-11-10
HUE055778T2 (hu) 2021-12-28
JP2022009374A (ja) 2022-01-14
CA3003076A1 (en) 2017-05-04
SI3368044T1 (sl) 2022-05-31
US20190060328A1 (en) 2019-02-28
US20240000804A1 (en) 2024-01-04
ES2883282T3 (es) 2021-12-07
AU2016344737C1 (en) 2021-10-07
WO2017072243A9 (en) 2018-07-26
PL3368044T3 (pl) 2021-12-20
TWI791420B (zh) 2023-02-11
AU2016344737B2 (en) 2021-07-08
KR20180098234A (ko) 2018-09-03
JP6999903B2 (ja) 2022-02-04
UY36967A (es) 2017-05-31
GB201518979D0 (en) 2015-12-09
RU2018119146A (ru) 2019-11-28
CN117379440A (zh) 2024-01-12
LT3368044T (lt) 2021-10-25
RS62764B1 (sr) 2022-01-31
AU2016344737A1 (en) 2018-05-17
EP3892281A2 (en) 2021-10-13
AU2016344737A9 (en) 2018-08-09
EP3892281A3 (en) 2021-11-10
EP3368044A1 (en) 2018-09-05
TW201720432A (zh) 2017-06-16
CN108778285A (zh) 2018-11-09
AR106505A1 (es) 2018-01-24
EP3368044B1 (en) 2021-06-09
KR102608158B1 (ko) 2023-11-29
RU2745606C2 (ru) 2021-03-29
IL258876B (en) 2022-03-01
CA3003076C (en) 2023-12-05
MX2018005252A (es) 2018-09-18
WO2017072243A8 (en) 2018-03-22
MA43106B1 (fr) 2021-09-30
IL258876A (en) 2018-06-28
MX2021007976A (es) 2021-08-16
MA43106A (fr) 2021-05-05
BR112018008496A2 (pt) 2018-10-23

Similar Documents

Publication Publication Date Title
DK3134530T3 (da) Behandling af hyperbilirubinæmi
DK3137169T3 (da) Hæmmere af lysin-specifik demethylase-1
DK3302565T3 (da) Faste doseringsformer af palbociclib
DK3102576T3 (da) Dihydropyrrolopyridininhibitorer af ror-gamma
DK3180331T3 (da) Polymorfer af selinexor
DK3160956T3 (da) Inhibitorer af lysin-specifik demethylase-1
DK3164380T3 (da) Hæmmere af lysinspecifik demethylase-1
DK3461891T3 (da) Nedstrømsbehandling af en alkalisk phosphatase
DK3102555T3 (da) Sammensætninger af forbindelser og anvendelser deraf
DK3458052T3 (da) Kombinationsbehandling af cancer
DK3307267T3 (da) Behandling af multipel sklerose
DK3283210T3 (da) Fremgangsmåde
DK3368044T3 (da) Behandling af hepatisk steatose-relateret oligo-ovulation
DK3132009T3 (da) Fremgangsmåde
DK3511000T3 (da) Krystallinsk form x2 af grapiprant
DK3201323T3 (da) Modificering af bakteriofag
DK3204352T3 (da) Hæmmere af lysin-gingipain
DK3297619T3 (da) Terapeutiske anvendelser af L-4-chlorkynurenin
DK3418273T3 (da) Derivater af flavagliner
DK3289363T3 (da) Specifik påvisning af clusterin isoformer
DK3073409T3 (da) Maskering af forskellige indholdstyper
DK3430004T3 (da) Faststofformer af nilotinibsalte
DK3173071T3 (da) Formularing af maropitant
FR3024647B1 (fr) Transat de puericulture
DK3200783T3 (da) Behandling af erytromelalgi